Massachusetts biotech hub is limping amid layoffs and low investment

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. If the Commonwealth of Massachusetts is a canary in the coal mine for the shape of the U.S. biotech industry, then hold onto your hats. Long home to some of the most concentrated and prolific hubs of biotech R&D, Massachusetts is witnessing a painful downturn in pipeline growth, venture funding, federal support and sector employment, according to a report from indust ...